237 related articles for article (PubMed ID: 29940415)
1. The structural basis for filovirus neutralization by monoclonal antibodies.
King LB; West BR; Schendel SL; Saphire EO
Curr Opin Immunol; 2018 Aug; 53():196-202. PubMed ID: 29940415
[TBL] [Abstract][Full Text] [Related]
2. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
[TBL] [Abstract][Full Text] [Related]
3. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
[TBL] [Abstract][Full Text] [Related]
4. Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies.
Rahim MN; Wang M; Wang T; He S; Griffin BD; Kobasa D; Yang R; Du Z; Qiu X
Viruses; 2019 Mar; 11(3):. PubMed ID: 30875741
[TBL] [Abstract][Full Text] [Related]
5. Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.
Ilinykh PA; Shen X; Flyak AI; Kuzmina N; Ksiazek TG; Crowe JE; Bukreyev A
J Virol; 2016 Apr; 90(8):3890-3901. PubMed ID: 26819310
[TBL] [Abstract][Full Text] [Related]
6. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.
Mire CE; Geisbert JB; Versteeg KM; Mamaeva N; Agans KN; Geisbert TW; Connor JH
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S384-8. PubMed ID: 25957964
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.
Nyakatura EK; Zak SE; Wec AZ; Hofmann D; Shulenin S; Bakken RR; Aman MJ; Chandran K; Dye JM; Lai JR
J Biol Chem; 2018 Apr; 293(16):6201-6211. PubMed ID: 29500195
[TBL] [Abstract][Full Text] [Related]
8. Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage.
Fenimore PW; Muhammad MA; Fischer WM; Foley BT; Bakken RR; Thurmond JR; Yusim K; Yoon H; Parker M; Hart MK; Dye JM; Korber B; Kuiken C
PLoS One; 2012; 7(10):e44769. PubMed ID: 23056184
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of serologic cross-reactivity using convalescent sera from filovirus-experimentally infected fruit bats.
Schuh AJ; Amman BR; Sealy TS; Flietstra TD; Guito JC; Nichol ST; Towner JS
Sci Rep; 2019 Apr; 9(1):6707. PubMed ID: 31040343
[TBL] [Abstract][Full Text] [Related]
10. Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.
Wirchnianski AS; Nyakatura EK; Herbert AS; Kuehne AI; Abbasi SA; Florez C; Storm N; McKay LGA; Dailey L; Kuang E; Abelson DM; Wec AZ; Chakraborti S; Holtsberg FW; Shulenin S; Bornholdt ZA; Aman MJ; Honko AN; Griffiths A; Dye JM; Chandran K; Lai JR
PLoS Pathog; 2024 Apr; 20(4):e1012134. PubMed ID: 38603762
[TBL] [Abstract][Full Text] [Related]
11. Achieving cross-reactivity with pan-ebolavirus antibodies.
King LB; Milligan JC; West BR; Schendel SL; Ollmann Saphire E
Curr Opin Virol; 2019 Feb; 34():140-148. PubMed ID: 30884329
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a putative filovirus vaccine: virus-like particles.
Martins KA; Warren TK; Bavari S
Virol Sin; 2013 Apr; 28(2):65-70. PubMed ID: 23385315
[TBL] [Abstract][Full Text] [Related]
13. The Role of Cytokines and Chemokines in Filovirus Infection.
Bixler SL; Goff AJ
Viruses; 2015 Oct; 7(10):5489-507. PubMed ID: 26512687
[TBL] [Abstract][Full Text] [Related]
14. Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.
Kozak R; He S; Kroeker A; de La Vega MA; Audet J; Wong G; Urfano C; Antonation K; Embury-Hyatt C; Kobinger GP; Qiu X
J Virol; 2016 Oct; 90(20):9209-23. PubMed ID: 27489269
[TBL] [Abstract][Full Text] [Related]
15. Filoviruses: One of These Things is (not) Like the Other.
Anthony SM; Bradfute SB
Viruses; 2015 Sep; 7(10):5172-90. PubMed ID: 26426036
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of Filovirus Infection of Rousettus aegyptiacus Bats in Zambia.
Changula K; Kajihara M; Mori-Kajihara A; Eto Y; Miyamoto H; Yoshida R; Shigeno A; Hang'ombe B; Qiu Y; Mwizabi D; Squarre D; Ndebe J; Ogawa H; Harima H; Simulundu E; Moonga L; Kapila P; Furuyama W; Kondoh T; Sato M; Takadate Y; Kaneko C; Nakao R; Mukonka V; Mweene A; Takada A
J Infect Dis; 2018 Nov; 218(suppl_5):S312-S317. PubMed ID: 29889270
[TBL] [Abstract][Full Text] [Related]
17. Vaccine research efforts for filoviruses.
Hart MK
Int J Parasitol; 2003 May; 33(5-6):583-95. PubMed ID: 12782057
[TBL] [Abstract][Full Text] [Related]
18. Filovirus vaccines.
Bradfute SB; Dye JM; Bavari S
Hum Vaccin; 2011 Jun; 7(6):701-11. PubMed ID: 21519188
[TBL] [Abstract][Full Text] [Related]
19. Potential vaccines and post-exposure treatments for filovirus infections.
Friedrich BM; Trefry JC; Biggins JE; Hensley LE; Honko AN; Smith DR; Olinger GG
Viruses; 2012 Sep; 4(9):1619-50. PubMed ID: 23170176
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis of Pan-Ebolavirus Neutralization by an Antibody Targeting the Glycoprotein Fusion Loop.
Murin CD; Bruhn JF; Bornholdt ZA; Copps J; Stanfield R; Ward AB
Cell Rep; 2018 Sep; 24(10):2723-2732.e4. PubMed ID: 30184505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
